MEDKIA - Company finances
|
EUR
|
2024
From: 2024-05-22
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 20,160 | 97,796 |
| Profit before tax | 2,865 | 6,868 |
| Net profit | 2,865 | 6,454 |
| Equity | 5,365 | 11,818 |
| Liabilities | 18,729 | 24,508 |
| Non-current assets | 0 | 0 |
| Current assets | 24,110 | 36,326 |
| Total assets | 24,110 | 36,326 |
|
Taxes paid
|
||
| STI taxes | 52 | - |
|
Financial indicators
|
||
| Revenue change y/y | - | +385.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 11.9% | 17.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 53.4% | 54.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.2% | 6.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 14.2% | 7.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 3.5 | 2.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,160 | 97,796 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDKIA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-06-02 | 1.29 |
| 2026-03-27 | 2026-03-27 | 291.24 |
| 2026-03-17 | 2026-03-23 | 291.24 |
| 2026-02-18 | 2026-02-25 | 291.24 |
MEDKIA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDKIA, UAB (code 306796354) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €97.8K and net profit of €6.5K, compared with revenue of €20.2K and net profit of €2.9K in 2024. This indicates very strong year-on-year revenue growth of 385.1%, while profitability remained positive as the business expanded. The profit margin was 6.6% in 2025, down from 14.2% in 2024, which suggests that higher sales were accompanied by a lower margin structure. At year-end 2025, total assets stood at €36.3K, with equity of €11.8K and liabilities of €24.5K, giving an equity ratio of 32.5% and a debt-to-equity ratio of 2.07. Asset turnover was 2.69x, reflecting active use of the asset base. Revenue per employee was €97.8K and profit per employee was €6.5K, pointing to solid productivity in the latest year.